About Wilson Therapeutics
Wilson Therapeutics is a company based in Stockholm (Sweden) founded in 2012 was acquired by Alexion in April 2018.. Wilson Therapeutics has raised $40 million across 2 funding rounds from investors including Alexion, Abingworth and MVM Partners. Wilson Therapeutics operates in a competitive market with competitors including Alnylam, Ultragenyx, Gemini Therapeutics, BioMarin Pharmaceutical and Mirum Pharmaceuticals, among others.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Wilson Therapeutics
Wilson Therapeutics has successfully raised a total of $40M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $29.73 million completed in December 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $29.7M
-
First Round
First Round
(14 Apr 2014)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2017 | Amount | Post-IPO - Wilson Therapeutics | Valuation |
investors |
|
| Apr, 2014 | Amount | Series B - Wilson Therapeutics | Valuation | Abingworth , MVM |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Wilson Therapeutics
Wilson Therapeutics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Alexion, Abingworth and MVM Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location | |
|
Healthcare real estate solutions are provided by HealthCap since 1996.
|
Founded Year | Domain | Location | |
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Wilson Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Wilson Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wilson Therapeutics Comparisons
Competitors of Wilson Therapeutics
Wilson Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alnylam, Ultragenyx, Gemini Therapeutics, BioMarin Pharmaceutical and Mirum Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of precision therapeutics for dry AMD and rare genetic diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic diseases are developed by BioMarin Pharmaceutical.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics are developed for rare diseases treatment.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for rare genetic diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wilson Therapeutics
Frequently Asked Questions about Wilson Therapeutics
When was Wilson Therapeutics founded?
Wilson Therapeutics was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Wilson Therapeutics located?
Wilson Therapeutics is headquartered in Stockholm, Sweden.
Is Wilson Therapeutics a funded company?
Wilson Therapeutics is a funded company, having raised a total of $40M across 2 funding rounds to date. The company's 1st funding round was a Series B of $40M, raised on Apr 14, 2014.
What does Wilson Therapeutics do?
Wilson Therapeutics was founded in 2012 in Stockholm, Sweden, within the biotechnology sector. Focus is placed on treatments for Wilson Disease, a rare genetic disorder involving copper accumulation in tissues. The lead product, WTX101, is advanced as a clinical-stage de-coppering agent. High-stability complexes with copper and proteins are formed by WTX101, which are excreted primarily via bile to restore impaired copper elimination in affected patients.
Who are the top competitors of Wilson Therapeutics?
Wilson Therapeutics's top competitors include Alnylam, BioMarin Pharmaceutical and Pharvaris.
Who are Wilson Therapeutics's investors?
Wilson Therapeutics has 4 investors. Key investors include Alexion, Abingworth, MVM Partners, and HealthCap.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.